Promacta Related Clinical Trials
EXTEND (Eltrombopag Extended Dosing Study) [Recruiting]
Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease [Recruiting]
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission [Recruiting]
Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag [Recruiting]
Milk-only Lactation Study for Patients on Eltrombopag [Not yet recruiting]
A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL) [Recruiting]
Eltrombopag and the Bcl-xL Pathway in Idiopathic Thrombocytopenic Purpura (ITP) [Recruiting]
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia [Recruiting]
Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag [Recruiting]
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) [Recruiting]
Eltrombopag Phase III Study In Chinese Chronic ITP Patients [Not yet recruiting]
LENS - Long-term Eltrombopag Observational Study [Recruiting]
Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation [Recruiting]
Promacta Pregnancy Registry [Recruiting]
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia [Recruiting]
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) [Recruiting]
Eltrombopag for Post Transplant Thrombocytopenia [Recruiting]
Eltrombopag for Management of Thrombocytopenia [Recruiting]
A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients [Not yet recruiting]
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) [Recruiting]
Effect of Eltrombopag Plus Granulocyte Colony-stimulating Factor (G-CSF) on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant (ASCT) [Recruiting]
Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Recruiting]
A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia [Recruiting]
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia [Recruiting]
Eltrombopag for Moderate Aplastic Anemia [Recruiting]
Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) [Recruiting]
Study of Eltrombopag in Platelet Refractory Thrombocytopenia [Recruiting]
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide [Recruiting]
Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation [Recruiting]
A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [Recruiting]
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) [Not yet recruiting]
Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390 [Recruiting]
Eltrombopag in Elderly Acute Myelogenous Leukemia (AML) [Recruiting]
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients [Recruiting]
|
